🇰🇷 Triferic in South Korea

Triferic (FERRIC PYROPHOSPHATE CITRATE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Triferic in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Hematology approved in South Korea

Frequently asked questions

Is Triferic approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Triferic in South Korea?

Rockwell Medical Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.